Hetero, Sun Pharma recall products in US over manufacturing issues
Hetero USA Inc is recalling 2,352 bottles of Pantoprazole Sodium delayed release tablets for "CGMP Deviations: Discoloration", the USFDA stated.
New Delhi: Drug makers Sun Pharma and Hetero are recalling products in the US market for manufacturing issues, according to the US Food and Drug Administration (USFDA). As per the US health regulator's latest Enforcement Report, the US-based arm of Sun Pharmaceutical Industries is recalling a generic drug indicated to raise blood pressure in adult patients with acute hypotension.Princeton...
New Delhi: Drug makers Sun Pharma and Hetero are recalling products in the US market for manufacturing issues, according to the US Food and Drug Administration (USFDA). As per the US health regulator's latest Enforcement Report, the US-based arm of Sun Pharmaceutical Industries is recalling a generic drug indicated to raise blood pressure in adult patients with acute hypotension.
The US is the world's largest market for pharmaceutical products.
Read also: Sun Pharma recalls over 34000 bottles of generic medication in US due to failed dissolution testing
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd